Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc.
497
mi
from 43215
Birmingham, AL
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc.
497
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc.
1654
mi
from 43215
Chandler, AZ
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc.
1654
mi
from 43215
Chandler, AZ
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research
1653
mi
from 43215
Chandler, AZ
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research
1653
mi
from 43215
Chandler, AZ
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc.
1662
mi
from 43215
Glendale, AZ
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc.
1662
mi
from 43215
Glendale, AZ
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage
1645
mi
from 43215
Mesa, AZ
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage
1645
mi
from 43215
Mesa, AZ
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage
1645
mi
from 43215
Mesa, AZ
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage
1645
mi
from 43215
Mesa, AZ
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc.
1662
mi
from 43215
Phoenix, AZ
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc.
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc.
1662
mi
from 43215
Phoenix, AZ
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc.
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc.
1662
mi
from 43215
Phoenix, AZ
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc.
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research
1653
mi
from 43215
Scottsdale, AZ
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research
1653
mi
from 43215
Scottsdale, AZ
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc.
1657
mi
from 43215
Tempe, AZ
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc.
1657
mi
from 43215
Tempe, AZ
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc.
1639
mi
from 43215
Tucson, AZ
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc.
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
1634
mi
from 43215
Tucson, AZ
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
1634
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research
2107
mi
from 43215
Santa Rosa, CA
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research
2107
mi
from 43215
Santa Rosa, CA
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc.
1942
mi
from 43215
Vista, CA
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc.
1942
mi
from 43215
Vista, CA
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc.
1157
mi
from 43215
Centennial, CO
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc.
1157
mi
from 43215
Centennial, CO
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage
1163
mi
from 43215
Colorado Springs, CO
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage
1163
mi
from 43215
Colorado Springs, CO
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
1153
mi
from 43215
Denver, CO
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
1153
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
837
mi
from 43215
Pinellas Park, FL
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
837
mi
from 43215
Pinellas Park, FL
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
436
mi
from 43215
Atlanta, GA
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research Inc.
274
mi
from 43215
Chicago, IL
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research Inc.
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage
279
mi
from 43215
Evansville, IN
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage
279
mi
from 43215
Evansville, IN
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage
678
mi
from 43215
Council Bluffs, IA
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage
678
mi
from 43215
Council Bluffs, IA
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
625
mi
from 43215
Edina, MN
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
625
mi
from 43215
Edina, MN
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage
698
mi
from 43215
Elkhorn, NE
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage
698
mi
from 43215
Elkhorn, NE
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage
712
mi
from 43215
Fremont, NE
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage
712
mi
from 43215
Fremont, NE
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage INC
682
mi
from 43215
Omaha, NE
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage INC
682
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage
1751
mi
from 43215
Henderson, NV
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage
1751
mi
from 43215
Henderson, NV
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc.
1762
mi
from 43215
Las Vegas, NV
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc.
1762
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
109
mi
from 43215
Akron, OH
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
109
mi
from 43215
Akron, OH
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
84
mi
from 43215
Cincinnati, OH
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
84
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc
1
mi
from 43215
Columbus, OH
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc
1
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc.
377
mi
from 43215
Anderson, SC
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc.
377
mi
from 43215
Anderson, SC
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
377
mi
from 43215
Anderson, SC
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
377
mi
from 43215
Anderson, SC
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research
350
mi
from 43215
Greer, SC
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research
350
mi
from 43215
Greer, SC
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
905
mi
from 43215
Dallas, TX
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
905
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Advantage, Inc.
896
mi
from 43215
Plano, TX
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Advantage, Inc.
896
mi
from 43215
Plano, TX
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc
1138
mi
from 43215
San Antonio, TX
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
1516
mi
from 43215
Murray, UT
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
1516
mi
from 43215
Murray, UT
Click here to add this to my saved trials
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
394
mi
from 43215
Saint Louis, MO
Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
A Phase 3, Observer-Blinded, Randomized, Active-Controlled (Engerix-B), Multicenter Trial of the Safety and Immunogenicity of HEPLISAV in Adults 18 to 70 Years of Age
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
394
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
A Study of LY3050258 in Healthy Participants
A Multiple-Dose, Dose Escalation, Safety, Tolerability, and Pharmacokinetic Study of LY3050258
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
1967
mi
from 43215
Cypress, CA
A Study of LY3050258 in Healthy Participants
A Multiple-Dose, Dose Escalation, Safety, Tolerability, and Pharmacokinetic Study of LY3050258
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1967
mi
from 43215
Cypress, CA
Click here to add this to my saved trials
Biomarker Assessment of Glutamatergic Target Engagement
Biomarker Assessment of Glutamatergic Target Engagement
Status: Enrolling
Updated:  12/31/1969
University of California-Davis
2043
mi
from 43215
Sacramento, CA
Biomarker Assessment of Glutamatergic Target Engagement
Biomarker Assessment of Glutamatergic Target Engagement
Status: Enrolling
Updated: 12/31/1969
University of California-Davis
2043
mi
from 43215
Sacramento, CA
Click here to add this to my saved trials
Biomarker Assessment of Glutamatergic Target Engagement
Biomarker Assessment of Glutamatergic Target Engagement
Status: Enrolling
Updated:  12/31/1969
Yale University
537
mi
from 43215
New Haven, CT
Biomarker Assessment of Glutamatergic Target Engagement
Biomarker Assessment of Glutamatergic Target Engagement
Status: Enrolling
Updated: 12/31/1969
Yale University
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Biomarker Assessment of Glutamatergic Target Engagement
Biomarker Assessment of Glutamatergic Target Engagement
Status: Enrolling
Updated:  12/31/1969
New York State Psychiatric Institute
481
mi
from 43215
New York, NY
Biomarker Assessment of Glutamatergic Target Engagement
Biomarker Assessment of Glutamatergic Target Engagement
Status: Enrolling
Updated: 12/31/1969
New York State Psychiatric Institute
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Status: Enrolling
Updated:  12/31/1969
Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center
347
mi
from 43215
Baltimore, MD
Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Status: Enrolling
Updated: 12/31/1969
Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center
347
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Multi-Colored Placido Disk Viability
Viability Study of a Multi-Colored Videokeratoscope With Extended Timescale Data
Status: Enrolling
Updated:  12/31/1969
The Flaum Eye Institute-University of Rochester
358
mi
from 43215
Rochester, NY
Multi-Colored Placido Disk Viability
Viability Study of a Multi-Colored Videokeratoscope With Extended Timescale Data
Status: Enrolling
Updated: 12/31/1969
The Flaum Eye Institute-University of Rochester
358
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Training Effects on Fuel Metabolism
Training Effects on Fuel Metabolism
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
Training Effects on Fuel Metabolism
Training Effects on Fuel Metabolism
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Translation Evaluation of Aging, Inflammation and HIV in Lung Function (TEAL)
Translation Evaluation of Aging, Inflammation and HIV in Lung Function
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Translation Evaluation of Aging, Inflammation and HIV in Lung Function (TEAL)
Translation Evaluation of Aging, Inflammation and HIV in Lung Function
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants
Effect of Evacetrapib on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
394
mi
from 43215
Madison, WI
Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants
Effect of Evacetrapib on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
394
mi
from 43215
Madison, WI
Click here to add this to my saved trials
Evaluation of Changes in Skin Carotenoid Scores in Medical Students Following Dietary Interventions
Evaluation of Changes in Skin Carotenoid Scores in Medical Students Following Dietary Interventions
Status: Enrolling
Updated:  12/31/1969
Texas Tech University Health Sciences Center
1130
mi
from 43215
Lubbock, TX
Evaluation of Changes in Skin Carotenoid Scores in Medical Students Following Dietary Interventions
Evaluation of Changes in Skin Carotenoid Scores in Medical Students Following Dietary Interventions
Status: Enrolling
Updated: 12/31/1969
Texas Tech University Health Sciences Center
1130
mi
from 43215
Lubbock, TX
Click here to add this to my saved trials